Mode
Text Size
Log in / Sign up

Kidney transplant recipients

Part of Kidney Diseases

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for kidney transplant recipients

5 trials tracked for kidney transplant recipients: 2 in phase 3 or 4 and 1 with published results. The most-cited published study has 35 citations.

5Trials tracked
2Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 2 Phase 2 3
  1. Phase 4 Envarsus XR Compared to Immediate Release Tacrolimus Completed · 35 cited
  2. Phase 4 Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients Completed
  3. Phase 2 Treg Modulation With CD28 and IL-6 Receptor Antagonists Completed
  4. Phase 2 COVID-19 Protection After Transplant Pilot Study Completed
  5. Phase 2 COVID Protection After Transplant-Immunosuppression Reduction Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found Updated — new results For clinicians

Kidney transplant recipients: what the trials found

Envarsus XR was evaluated for its impact on Calcineurin Inhibitor-related Symptoms (CIRS). While there was no statistically significant mean change in the overall CIRS severity score (-2.977; -3.139, p=0.944) or in any of the five individual CIRS items (p=0.345), a statistically significant difference was observed in the number of subjects with moderately severe, severe, or very severe scores on any CIRS item (18 vs 28, p=0.010).

Mycophenolic acid was utilized in patients post-transplant to manage and monitor for biopsy-confirmed acute rejection based on Banff '97 criteria.

Recent results — preliminary, needs further review

  • Pfizer-BioNTech COVID-19 Vaccine 2023-2024: Evaluated antibody titer fold changes and incidence of local/systemic adverse reactions following vaccination in transplant recipients.
  • BNT162b2 vaccine (Pfizer/BioNTech): Investigated in a phase 2 trial for this population.

For the clinician treating this condition

  • Envarsus XR shows a statistically significant reduction in the number of patients experiencing severe symptoms related to calcineurin inhibitors, despite no significant change in mean severity scores.
  • Mycophenolic acid is established in the management of transplant recipients regarding biopsy-confirmed acute rejection.

AI synthesis of 0 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Kidney Diseases

Related studies from across the Kidney Diseases family.

SGLT2 inhibitors provide the greatest risk reduction for kidney outcomes in type 2 diabetes
Drug Pipeline Meta-analysis
SGLT2 inhibitors provide the greatest risk reduction for kidney outcomes in type 2 diabetes SGLT2 Inhibitors Lead in Kidney Protection for Diabetes and CKD
This network meta-analysis of 20,521 patients with type 2 diabetes and chronic kidney disease found that SGLT2 inhibitors demonstrated the g…
A new analysis of over 20,000 patients shows SGLT2 inhibitors, semaglutide, and finerenone all protect kidneys in type 2 diabetes and chroni…
Higher CGM-derived time in range is associated with lower odds of diabetic kidney disease
Diabetes & Endocrinology Meta-analysis
Higher CGM-derived time in range is associated with lower odds of diabetic kidney disease Higher time in range from glucose monitors linked to kidney health
This meta-analysis of 7182 adults with type 1 or type 2 diabetes found that a 10% increase in time in range (TIR) was associated with lower …
Maintaining a steady blood sugar range may help protect the kidneys in people living with type 1 and type 2 diabetes.
High triglyceride-glucose index increases major adverse cardiocerebrovascular events in patients with CKM syndrome
Diabetes & Endocrinology Meta-analysis
High triglyceride-glucose index increases major adverse cardiocerebrovascular events in patients with CKM syndrome High triglyceride and glucose levels linked to heart and brain risks
This meta-analysis of over 2 million participants found that the highest TyG index category is associated with a 1.20 risk of MACCE compared…
A large study of over 2 million people shows that a specific marker for blood fats and sugar may signal higher risks for heart and brain iss…
Fisetin shows potential as a nutritional senotherapeutic but lacks clinical evidence for chronic kidney disease
Neurology Sys. Review
Fisetin shows potential as a nutritional senotherapeutic but lacks clinical evidence for chronic kidney disease Fisetin shows potential for managing chronic kidney disease
This mini review explores the potential of Fisetin as a nutritional senotherapeutic for age-related diseases. The authors conclude that whil…
A natural compound called fisetin may help target age-related issues in the kidneys, though more clinical evidence is needed to confirm its …
AKI Affects 30.7% of Pediatric Liver Transplant Recipients in Pooled Analysis
Pediatrics Meta-analysis
AKI Affects 30.7% of Pediatric Liver Transplant Recipients in Pooled Analysis Identifying risk factors for kidney damage after pediatric liver transplants
This meta-analysis pooled data from 2986 pediatric liver transplant recipients to estimate the incidence of acute kidney injury and examine …
Doctors are looking for ways to protect the kidneys of children undergoing liver transplants, where about 31% face sudden kidney injury.
CD4+ T cell subset imbalance drives renal inflammation and fibrosis in diabetic kidney disease
Allergy & Immunology Sys. Review
CD4+ T cell subset imbalance drives renal inflammation and fibrosis in diabetic kidney disease T Cell Imbalance Linked to Kidney Damage in Diabetic Patients
This narrative review explores the role of CD4+ T cell subset imbalances in the progression of diabetic kidney disease. The authors synthesi…
New research highlights how specific immune cell imbalances may drive inflammation and scarring in people with diabetic kidney disease.
Healthyer dietary patterns and physical activity may improve renal and metabolic outcomes in type 2 diabetes
Nutrition & Obesity Medicine Meta-analysis
Healthyer dietary patterns and physical activity may improve renal and metabolic outcomes in type 2 diabetes Healthy eating and exercise help manage kidney disease and diabetes
This systematic review of 31 studies examined dietary patterns, physical activity, and supplements for older adults with type 2 diabetes and…
Specific dietary patterns and regular physical activity show promise in managing blood pressure and kidney health for people with type 2 dia…
Controlled low central venous pressure with nitroglycerin reduces 7-day postoperative AKI by 14.9% absolute risk
Pulmonology & Critical Care RCT
Controlled low central venous pressure with nitroglycerin reduces 7-day postoperative AKI by 14.9% absolute risk Nitroglycerin may lower kidney injury risk after heart surgery
This randomized controlled trial of 505 patients undergoing cardiac surgery found that controlled low central venous pressure (CLCVP) using …
A new trial shows that using nitroglycerin to manage blood pressure during heart surgery can reduce the risk of early kidney damage.
Astragaloside IV significantly reduces renal fibrosis markers and serum creatinine in preclinical animal models
Drug Pipeline Meta-analysis
Astragaloside IV significantly reduces renal fibrosis markers and serum creatinine in preclinical animal models Astragaloside IV Shows Potential for Treating Chronic Kidney Disease
This meta-analysis of preclinical animal studies indicates that Astragaloside IV significantly reduces serum creatinine, blood urea nitrogen…
Early research in animal models suggests that Astragaloside IV may reduce key markers of kidney damage and fibrosis in chronic kidney diseas…
Gut-kidney axis drives sepsis-associated AKI, review argues for microecological and neuromodulatory therapies
Nephrology Sys. Review
Gut-kidney axis drives sepsis-associated AKI, review argues for microecological and neuromodulatory therapies New Approaches Target Gut Health to Treat Sepsis Kidney Damage
This systematic review examines the gut-kidney axis as a mechanistic driver of sepsis-associated acute kidney injury and evaluates microecol…
New research explores how targeting the gut-kidney axis could help treat and prevent kidney damage in patients with sepsis.
Four mailer types aim to increase health care proxy documentation in patients with chronic conditions
Primary Care & Family Medicine RCT
Four mailer types aim to increase health care proxy documentation in patients with chronic conditions New trial plans to use mailers to help patients name proxies
This study protocol describes a factorial randomized trial of approximately 20,000 patients with cancer, congestive heart failure, or chroni…
A new study plans to see if different types of mailers can help patients with serious illnesses name a healthcare proxy.
High abdominal aortic calcification index predicts poorer cardiovascular event-free survival in patients with chronic kidney disease
Rheumatology Meta-analysis
High abdominal aortic calcification index predicts poorer cardiovascular event-free survival in patients with chronic kidney disease High Abdominal Aortic Calcification Linked to Worse Outcomes in Kidney Disease
This meta-analysis of 1,914 patients found that high abdominal aortic calcification index (ACI) is associated with significantly worse cardi…
High levels of calcium buildup in the aorta are linked to a higher risk of heart issues and lower survival in patients with chronic kidney d…